PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,307 | +50.2% | 55,850 | +21.7% | 0.07% | +61.9% |
| Q2 2023 | $52,792 | +6.8% | 45,906 | -1.6% | 0.04% | +23.5% |
| Q1 2023 | $49,449 | -53.2% | 46,650 | -32.9% | 0.03% | -53.4% |
| Q4 2022 | $105,637 | +7.8% | 69,498 | +50.2% | 0.07% | +10.6% |
| Q3 2022 | $98,000 | +46.3% | 46,276 | -7.0% | 0.07% | +57.1% |
| Q2 2022 | $67,000 | -55.6% | 49,776 | -30.4% | 0.04% | -55.8% |
| Q1 2022 | $151,000 | -42.4% | 71,547 | +1.2% | 0.10% | -49.7% |
| Q4 2021 | $262,000 | -30.1% | 70,675 | -6.1% | 0.19% | -31.0% |
| Q3 2021 | $375,000 | -16.9% | 75,241 | +8.8% | 0.27% | -27.1% |
| Q2 2021 | $451,000 | +1.6% | 69,141 | +7.3% | 0.38% | -0.3% |
| Q1 2021 | $444,000 | -32.0% | 64,441 | +0.6% | 0.38% | -29.9% |
| Q4 2020 | $653,000 | +310.7% | 64,041 | +41.2% | 0.54% | +320.3% |
| Q3 2020 | $159,000 | – | 45,341 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |